Creutzfeldt–Jakob disease and other prion diseases

I Zerr, A Ladogana, S Mead, P Hermann… - Nature Reviews …, 2024 - nature.com
Prion diseases share common clinical and pathological characteristics such as spongiform
neuronal degeneration and deposition of an abnormal form of a host-derived protein, termed …

Cellular models for discovering prion disease therapeutics: Progress and challenges

SH Krance, R Luke, M Shenouda… - Journal of …, 2020 - Wiley Online Library
Prions, which cause fatal neurodegenerative disorders such as Creutzfeldt‐Jakob disease,
are misfolded and infectious protein aggregates. Currently, there are no treatments available …

Pharmacological inactivation of the prion protein by targeting a folding intermediate

G Spagnolli, T Massignan, A Astolfi, S Biggi… - Communications …, 2021 - nature.com
Recent computational advancements in the simulation of biochemical processes allow
investigating the mechanisms involved in protein regulation with realistic physics-based …

Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies

L Linsenmeier, B Mohammadi, M Shafiq, K Frontzek… - Science …, 2021 - science.org
The prion protein (PrPC) is a central player in neurodegenerative diseases, such as prion
diseases or Alzheimer's disease. In contrast to disease-promoting cell surface PrPC …

Therapeutic targeting of cellular prion protein: toward the development of dual mechanism anti-prion compounds

A Masone, C Zucchelli, E Caruso… - Neural Regeneration …, 2025 - journals.lww.com
PrP Sc, a misfolded, aggregation-prone isoform of the cellular prion protein (PrP C), is the
infectious prion agent responsible for fatal neurodegenerative diseases of humans and …

Calcineurin controls cellular prion protein expression in mouse astrocytes

G Dematteis, E Restelli, VV Vanella, M Manfredi… - Cells, 2022 - mdpi.com
Prion diseases arise from the conformational conversion of the cellular prion protein (PrPC)
into a self-replicating prion isoform (PrPSc). Although this process has been studied mostly …

Novel regulators of PrPC expression as potential therapeutic targets in prion diseases

A Colini Baldeschi, S Vanni, M Zattoni… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction Prion diseases are rare and fatal neurodegenerative disorders. The key
molecular event in these disorders is the misfolding of the physiological form of the cellular …

Characterization of physical, mechanical, and biological properties of SilkBridge nerve conduit after enzymatic hydrolysis

S Biggi, GA Bassani, V Vincoli, D Peroni… - ACS Applied Bio …, 2020 - ACS Publications
The in vitro degradation profile and the cytotoxicity of the degradation products of a silk
fibroin (SF)-based nerve conduit (SilkBridge), with a complex three-layered wall architecture …

[HTML][HTML] Perspectives on CRISPR Genome Editing to Prevent Prion Diseases in High-Risk Individuals

MM Medd, Q Cao - Biomedicines, 2024 - mdpi.com
Prion diseases are neurodegenerative disorders caused by misfolded prion proteins.
Although rare, the said diseases are always fatal; they commonly cause death within months …

A tetracationic porphyrin with dual anti-prion activity

A Masone, C Zucchelli, E Caruso, G Lavigna, H Eraña… - Iscience, 2023 - cell.com
Prions are deadly infectious agents made of PrP Sc, a misfolded variant of the cellular prion
protein (PrP C) which self-propagates by inducing misfolding of native PrP C. PrP Sc can …